Few oncologists use dexamethasone to reduce end-stage cancer-related fatigue, even though it can improve quality of life and reduce physical distress, palliative care researchers at the University of Texas M.D. Anderson Cancer Center reported in the Journal of Clinical Oncology. Lead author Dr. Sriram Yennurajalingam said the steroid gets limited use due to concerns about side effects and a lack of study data, but up to two weeks' treatment is an option for all advanced-cancer patients.

Related Summaries